Succinate forms and compositions of Bruton's tyrosine kinase inhibitors

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 11174243
APP PUB NO 20210032218A1
SERIAL NO

16319506

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention provides compounds and compositions thereof which are useful as inhibitors of Bruton's tyrosine kinase and which exhibit desirable characteristics for the same.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
VIRACTA THERAPEUTICS INC2533 S COAST HWY 101 SUITE 210 CARDIFF CA 92007

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Macphee, J Michael Cambridge, US 6 23
Neuman, Linda L South San Francisco, US 1 0

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
3.5 Year Payment $1600.00 $800.00 $400.00 May 16, 2025
7.5 Year Payment $3600.00 $1800.00 $900.00 May 16, 2029
11.5 Year Payment $7400.00 $3700.00 $1850.00 May 16, 2033
Fee Large entity fee small entity fee micro entity fee
Surcharge - 3.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00